Skip to main content
OpenTrials

Clinical trial condition

Dementia

Explore clinical trials studying Dementia. Study availability and eligibility vary by location and protocol.

2,729 public trials 503 recruiting studies
Refine in advanced search Browse all conditions

Dementia trial results

Completed

A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

NCT05619692

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +11 more
Locations
  • Sage Investigational Site Gilbert, Arizona, United States
  • Sage Investigational Site Phoenix, Arizona, United States
  • Sage Investigational Site Lafayette, California, United States
  • Sage Investigational Site Long Beach, California, United States
View all 39 locations
View Trial Details
Completed

A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)

NCT05107128

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • Sage Investigational Site Little Rock, Arkansas, United States
  • Sage Investigational Site La Jolla, California, United States
  • Sage Investigational Site Los Angeles, California, United States
  • Sage Investigational Site Sacramento, California, United States
View all 49 locations
View Trial Details
Completed

28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease

NCT05358821

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations
  • Sage Investigational Site Birmingham, Alabama, United States
  • Sage Investigational Site Los Alamitos, California, United States
  • Sage Investigational Site Englewood, Colorado, United States
  • Sage Investigational Site Washington D.C., District of Columbia, United States
View all 14 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

NCT04602624

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +9 more
Locations
  • Sage Investigational Site Phoenix, Arizona, United States
  • Sage Investigational Site Redlands, California, United States
  • Sage Investigational Site Miami, Florida, United States
  • Sage Investigational Site St. Petersburg, Florida, United States
View Trial Details
Completed

Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment

NCT03446001

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Xenoscience Phoenix, Arizona, United States
  • Arizona Research Center Phoenix, Arizona, United States
  • Imaging Endpoints Research Scottsdale, Arizona, United States
  • Atria Clinical Research Little Rock, Arkansas, United States
View all 103 locations
View Trial Details
Completed

GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)

NCT05189210

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • First Choice Neurology - Aventura Neurologic Associates Adventura, Florida, United States
  • Finlay Medical Research Corporation - Greenacres Greenacres City, Florida, United States
  • Outpatient Psy Care Miami, Florida, United States
  • Finlay Medical Research Corporation - Miami Dade Miami, Florida, United States
View all 35 locations
View Trial Details

Related conditions